High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis.
Pharmaceuticals (Basel, Switzerland)（2023）
摘要
NLR may be a potential marker for predicting the clinical response and persistence of TNF-α blockers in AS patients.
更多查看译文
关键词
ankylosing spondylitis (AS),biomarkers,blood cells,treatment outcome,tumor necrosis factor-alpha (TNF-α)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要